chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt recv vax on 2/25/99; approx 20 min post vax pt exp wheezing, hives & shortness of breath; tx=Benadryl, Epinephrine, IV fluids, oxygen
pt recvd vax 18MAR93 & following vax pt did not feel well & devel a fever w/chills; pt required a MD visit; sx persisted for 2 days; pt recovered by 21MAR93;
Started with joint aches throughout whole body. Nausea, chills, uncontrollable shivering, high temp at 99 on day 1, 102 on day 2, cold sweat. Joint ache, nausea continue on day 3, temp read 97 on day 3. Patient took OTC Acetaminophen 500 mg for pain relief.
WIthin 24 hrs of vaccinations being administered my son, who has never been ill, spiked a fever of 103.  He had a trip to the Er, a house call and a follow up visit with his primary physican during the next 3 days.  His fever did not subside for four days.  Four weeks later he developed a case of chicken pox, one of the shots he had been given.  The dr was surprised at the severity of his case as well as the timing.  He firmly believes the fever following his vacinations is directly related to his immunizations.
22 month old male came 8-14-08, imm delay - needed imm listed below to update status.  Well at visit.  Mom called next am stating fever and "not walking".  Child seen in office 8-15-08.  Fever 102.1, only obvious symptom.  Negative 1s to complete vaccine series in 6 months (Dtap; Hep A).
This spontaneous case reported by a consumer, describes the occurrence of headache and vomiting in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Feb 24, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Feb 24, 2021, patient experienced headache and vomiting. Patient treated with Zofran (ondansetron hydrochloride dihydrate) ongoing since an unknown date; at an unspecified dose and frequency. At the time of the report, headache and vomiting outcome: unknown/not provided. Action taken with mRNA-1273 in response to the events: not applicable. Concomitant product use not provided. This case linked to MOD-2021-221339 (patient link).
Swelling of lymphnode under armpit of right arm. Was told it was a normal side effect and to add ice to the area to reduce swelling and ease the discomfort. The lymphnode swelling has not subsided and feels as if it has grown larger. The tenderness around the left arm has spread and now I have developed a fever that one doctor has described as life threatening.
Patient did not actually receive the small pox vaccine.  Patient hugged a person who was vaccinated with the smallpox vaccine on the same day; person with the vaccine had uncovered sleeves, but a 4x4 and a tegaderm on the vaccine site
Information has been received from a female pt who as a child was vaccinated with MMR II. Subsequently, she developed measles and mumps. The reported indicated that the titer for rubella had been negative. Unspecified medical attention was sought. Additional info has been requested. The pt also indicated a similar experience with MMR II (WAES0304USA02938).
Right deltoid red and warm to touch. 2 1/2 inches wide by 3 1/2 inches long.
Patient became dizzy approximately 5 minutes after vaccination. He stated that he doesn't feel good and "I think I am going to pass out". while he laid on the floor to get comfortable. Upon assessment, pt. appear to be pale and diaphoretic, alert and oriented to self, time, place and situation, BP 83/50, HR 63, T 98.3 F, SPO2 96% @ room air. 15 minutes later, pt. stated that he feels better while he sips on a bottle of water offered to him BP 86/63 HR 64 T 98.1F SPO2 97% @room air. Another set of vitals taken 15 minutes later BP 91/71 HR 64 T 98.1F SPO2 98% @ room air while pt. skin color return to normal. Pt stated that he feels okay while we continue to monitor for 30 minutes.
IgAN relapses; Subnephrotic Range Proteinuria; Gross hematuria; This is a literature report.  A 38-year-old female patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history included: "severe acute respiratory syndrome coronavirus 2" (ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1,SINGLE), for covid-19 immunization. The following information was reported: IGA NEPHROPATHY (medically significant), outcome "unknown", described as "IgAN relapses"; HAEMATURIA (non-serious), outcome "recovered"(Duration: 3 days), described as "Gross hematuria"; PROTEINURIA (non-serious), outcome "unknown", described as "Subnephrotic Range Proteinuria".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the currently available information the possibility of causal association between the event IgAN relapses and the suspect drug BNT162B2  cannot be ruled out. The case will be reassessed once new information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate,Linked Report(s) : US-PFIZER INC-202200589587 Same article/drug/event and different patient
tingling sensation on her foot, tingling sensation on her r right lower leg and foot became consistent and left leg also feels the same at times but not as consistent as her right leg; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling sensation on her foot, tingling sensation on her r right lower leg and foot became consistent and left leg also feels the same at times but not as consistent as her right leg) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced PARAESTHESIA (tingling sensation on her foot, tingling sensation on her r right lower leg and foot became consistent and left leg also feels the same at times but not as consistent as her right leg). At the time of the report, PARAESTHESIA (tingling sensation on her foot, tingling sensation on her r right lower leg and foot became consistent and left leg also feels the same at times but not as consistent as her right leg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were triseminal indicated for Birth control.  Treatment details included Currently on steroids as prescribed.
Arm hurt at injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (Arm hurt at injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019F21A) for COVID-19 vaccination.     Patient had no allergies (medications, food and other products), Patient never had COVID positive test or diagnosis. Patient not received other vaccines within 1 month prior to Moderna COVID-19 vaccine.  Previously administered products included for Product used for unknown indication: JANSSEN COVID-19 VACCINE (received the Johnson and Johnson vaccine 1st dose and it almost kill her, she was down for 6 weeks, Lot number: 1805075 /1805025 and Route: IM) on 25-Mar-2021. Past adverse reactions to the above products included Vaccination adverse reaction with JANSSEN COVID-19 VACCINE. Concurrent medical conditions included Thyroid disorder (Thyroid problem) and Autoimmune disorder (Autoimmune system).    On 24-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm hurt at injection site). At the time of the report, VACCINATION SITE PAIN (Arm hurt at injection site) had resolved.            No concomitant medications were reported.  She stated she had received the Moderna vaccine 6 months later, two doses of Moderna vaccine. Reported that her arm hurts for a day after receiving the first booster dose.  No treatment medications were reported.   This case was linked to MOD-2022-640754 (Patient Link).
Tinnitus, gradually growing more intense as time goes on. It's a wavering, buzzing sound, like cicadas.
Loud involuntary vocal tics... they sound like a cross between a cough/sneeze.  The first time we noticed them was immediately following school and they continued for more than an hour.  They now occur off and on daily and can occur as a single tic or multiple tics over the course of an hour.
This spontaneous report as received from a physician refers to an about 80 years old male patient. The patient was vaccinated SC with single 0.65 ml dose of ZOSTAVAX in approximately 2009 ("2 to 3 years ago"). No other co-suspects were reported. No concomitant medications were reported. Subsequently, the patient had a skin rash. The outcome of skin rash was reported as recovered (date unspecified). Additional information is not expected.
Moderna COVID-19 Vaccine EUA.  Patient was given their second dose of Moderna COVID 19 vaccine 7 days too early.  No adverse reactions.  Contacted Moderna and they said to repeat dose in next 4-8 weeks for dose to count- case #MOD22-021325.
Large (15 cm) local reaction in area of Pneumovax administration on lower outer upper arm.  No fevers/lymphagiitis/other skin changes.  Smaller red area in location of flu shot given higher up on arm in same arm.
COVID-19 breakthrough. I started off with a wet cough in the back of the throat and it traveled up to my sinuses. I had sensitivity to light and sound. I was also extremely fatigued. Its been very similar to a sinus cold with an extra cough. The worst of it was from the 4/10/2022-4/14/2022. Now its pretty much just a lulling cough that I can take a cough drop for and be okay.
ON 08/23/2021, PATIENT REQUESTED JANSSEN COVID-19 VACCINE. PATIENT WILLINGLY FILLED OUT CONSENT FORM AND SIGNED AND DATED, THEN PROCEEDED TO WAIT UNTIL ADMINISTERING STAFF PREPARED VACCINATION FOR PATIENT. PATIENT ASKED IF WE "PLUNGED"  THE VACCINE WHILE ADMINISTERING VIA INTRAMUSCULAR ROUTE. ADMINISTERING TECHNICIAN EXPLAINED THE TECHNIQUE THAT WAS TAUGHT DURING COMPANY  CERTIFICATION TRAINING VIDEO THROUGH STATE UNIVERSITY AND SKILLS CHECK, BEING THE Z-TRACK METHOD, AND DEMONSTRATED TECHNIQUE BEFORE ADMINISTERING TO ENSURE PATIENT WAS COMFORTABLE AND INFORMED. ADMINISTERING TECHNICIAN ASKED IF PATIENT WAS COMFORTABLE PROCEEDING, WHICH THE PATIENT SAID "YES". ADMINISTERING TECHNICIAN PROCEEDED TO VACCINATE AND APPLY BANDAID (PATIENT DID NOT BLEED DURING OR AFTER ADMINISTRATION). PATIENT THEN WAS ADVISED TO WAIT IN THE WAITING AREA AFTER VACCINATION FOR 15 MINUTES OF MONITORING AS ADVISED BY THE CDC. UPON LEAVING, PATIENT WAVED GOODBYE AND SAID HE "FELT FINE" AND PROCEEDED TO LEAVE THE PHARMACY AREA. WHILE WALKING TO THE FRONT DOOR, PATIENT STOPPED THE FRONT STORE STAFF AND ASKED IF PHARMACY WAS AFFILIATED COMPANY AND FURTHER ASKED FOR OUR CORPORATE PHONE NUMBER.  THE FRONT STORE STAFF PROCEEDED TO GIVE PATIENT THE COMPANY PHONE NUMBER AS REQUESTED. NO FURTHER CONTACT WAS MADE TO THE PHARMACY STAFF AFTER THE PATIENT LEFT THE PHARMACY ON 08/23/2021. NO ERROR WAS MADE BY PHARMACY STAFF, HOWEVER, DOCUMENTATION WAS REQUESTED BY CORPORATION ON OUR BEHALF.
Information has been received from a physician concerning a 11 year old male with no pertinent medical history or drug allergies who in July 2007, was vaccinated IM with his first 0.5 ml dose of VAQTA. Subsequently after administration, the patient developed swelling about the size of a baseball at the site of injection. The patient contacted the office via telephone for medical attention. No labs or diagnostic studies were performed. The patient was treated with ice and BENADRYL. Subsequently, the patient recovered on an unspecified date. There was no product quality complaint. No additional information was provided. Additional information has been received from a physician concerning a 10 year old male who received VAQTA. The patient had a large local reaction. He was allergy tested to lot number "AHAVB223AA" in the office, which was negative. The patient received the second dose on 17-JUL-2008 with no reaction. Additional information is not expected.
chills; fever; lymph node swelling; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete;  unknown manufacturer), for COVID-19 immunization. The following information was reported: CHILLS (non-serious), outcome "unknown"; PYREXIA (non-serious), outcome "unknown", described as "fever"; LYMPHADENOPATHY (non-serious), outcome "unknown", described as "lymph node swelling".  Additional information: It was also reported that event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
HAD RECEIVED 2ND MODERNA VACCINE ON 03/20/2022,   ADMINISTER THESE AS 1ST BOOSTER DOSE AT 10 WEEKS INSTEAD OF 5 MONTHS ON 05/31/2022.  NO NOTED REPORTED SIGNS OR SYMPTOMS OR TREATMENT REQUIRED FROM RECEIVING TO EARLY. UNDERSTAND DO NOT NEED TO REPEAT DOSE
Headache lasting 4 days solid. It is now intermittent. When headache was constant, I also got a Migraine headache that started on day 2 and ended midway through day 4. The Migraine may or may not be related. I sometimes still get them during my period even though I take Topiramate as a preventative.   I am also experiencing an increase in fatigue and slept excessively the first 4 days. The pain from my fibromyalgia spiked hard on day 2 and three. I am still in a flare.
Patient fainted after needle was withdrawn, lost consciousness for 2 seconds. Mother of patient called our office the next day stating that patient collapsed in coffee shop after having left the clinic. Patient was observed in exam room for 15 minutes, and was released without problem.
I had the dose on 04/09/2021 and on 04/12/2021 I started having some symptoms and on Tuesday I started having a lot of anxiety and panic and chest pain. I could not breathe. I ran outside and my husband behind me. I told him I was not feeling well. We called an ambulance and they checked me at home. They told me my vitals were ok but they said if I wanted to go to the hospital I could but I did not. I have felt changes in me. I always have headaches and anxiety. Sometimes I do not do my house chores because I get tired. I still have the chest pain. Sometimes I cannot take care of my kids because the symptoms do not let me. I have not taken any medication. My doctor did some blood work and it was normal.
Patient complained of feeling hot and became nauseated.  Gave him water and a fan.  Stated he was feeling better after 3-4 minutes.  Then about 20 minutes after receiving vaccine he started to feel hot, nauseated, and DIZZY.  Checked BP 180/106, P-85, O2 99%. Patient is currently staying in a drug and alcohol rehabilitation center, and called their driver to transport him to the nearest emergency room.  Patient did not want to go by ambulance or have them called.  Patient was not in any distress or having breathing difficulty.  We called the facility he is staying at this morning and they stated "he's fine today," and he is up doing all of his daily routine this morning.  No further information was given on condition or what treatment or tests were conducted at the emergency room.  We are under the assumption the patient actually went to the ER, but cannot confirm at this time.
28Sep2023 evening: injection site pain 29Sep2023 around 12:00pm: fatigue, body aches, chills, loss of appetite 30Sep2023 around 4:30am: syncope 30Sep2023 around 9:00am: rash on neck, face, and near injection site on left arm 01Oct2023: itching of rash on left arm which is continuing as of 06Oct2023 (all other symptoms resolved prior)
05/02/2005 4 year old, immunizations given came in 05/04 for left thigh swelling, red with fever - 3 1/2 inches - 12.2 inches thigh area, site for DTAP and IPV.  Benadryl given only.
Pt given varicella SQ in LT. Within 5 minutes noted area of injection site became red and swollen. Approx 3x4cm. No other signs or symptoms noted. Ice Pack applied to area. Area checked Frequently, 15 min. pt smiling, drinking juice, red area fading and eventually decreased. After 30 minutes area much smaller slightly pink and Pt sent home.
pt recv vax 5JAN96 & 6JAN96 2PM pt had a sz lasting <2min;transported to hosp;sleepy afterwards;high fever of 104.5, febrile sz;
Pinched nerve; Pain in his neck or shoulder; Pain in his neck or shoulder; This is a spontaneous report from a contactable consumer (patient). A 45-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration, on 28Jan2021, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The first dose of the COVID-19 vaccine was on 28Jan2021. On 15Feb2021, the patient started experiencing pain in his neck or shoulder. On an unspecified date, the patient had pinched nerve in his neck; the patient was prescribed prednisone. They gave the patient prednisone to take but he was holding off to take prednisone because he was afraid it will hinder the immune response to the vaccine. The patient was holding off to take prednisone, but he wanted to get a professional opinion on when he should get or the time to start taking prednisone. The patient wanted to know if taking it will change the efficacy of the vaccine. The patient was asking if this would affect the vaccine's efficacy. The patient had the second dose on 17Feb2021 (day before the reporting) at 9:20 in the morning. The patient also asked if it was safe for pregnant women to get the vaccine. The outcome of the events was unknown.  Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.
3:50 PM pt. presented a rash all over the body, after vaccine administration. She was evaluated by the Dr who ordered BENADRYL 5ml stat PO given at 4:30pm and was left for observation. At 4:50pm the doctor reevaluated the patient and observed the rash had disappeared and discharged her with instructions to continue treatment with BENADRYL 12.5mg/5ml PO Q6hrs and to go to the ER if worsen.
Developed stinging pain (that awakened me in the middle of the night) and numbness in (L) arm one week post flu immunization (L) arm. Episodes occurred frequently for 3 weeks til I went to Occ Helath and received MEDROL Dose Pak and NAPROSYN.
This spontaneous report was received from a registered nurse referring to unspecified number of patients of unknown ages and genders. On unspecified dates in 2014, doses of PNEUMOVAX 23 (Lot# and expired date unspecified) and other vaccines (captured in MARRS# 1409USA008659, 1409USA008509, 1409USA006676, 1409USA008510, 1409USA008511, 1409USA008514) were administrated to unspecified patients (dose, frequency and route unspecified), after exposed to temperatures of 10 C degree for 37.5 hours/temperature excursions on 08-AUG-2014, 13-AUG-2014 and 28-AUG-2014. No adverse effect has been reported. This is one of several reports from the same source. Additional information has been requested.
Patient received high dose Fluzone.  Erythema, induration, and inflammation occurred at injection site almost immediately.  Patient sat for 20 minutes after injection so that she could be observed.  I advised her to apply an ice pack to assist her with the swelling.
11 hours after vaccine my daughter complained of chills and body aches then by morning she had a fever with chills/body aches/ headache. She spiked a fever a few times that day and as high as 103.7 at 1030pm on Dec 11. She received Motrin and then at 5am Tylenol for another fever. She then complained on stomach pain with multiple episodes of diarrhea on dec 12 as well as a fever that night of 102 with severe headache, body aches/joint pain/chills which she then received Motrin and was taken to the Emergency room where she tested negative for rsv/influenza/covid. She was given oral Tylenol and intravenous fluids as well as zofran and was discharged. Dec 13 she missed school due to her recent ER visit and had multiple more episodes of diarrhea and fatigue. She then complained of fatigue for the next 2 days and still is not 100%.
Fever, chills, fatigue, nausea, diarrhea, bad pain in arm-throbbing and burning, headache
Information has been received from a health professional concerning an adult female patient who in 2006 ("recently") was vaccinated IM with a 0.5 mL dose of Pneumovax 23 (possibly Lot# 655501/1035F).  Subsequently, (2006) the patient developed an injection site reaction to include local pain, redness, general malaise and fever up to 102 F.  It was also reported that the "patient had redness that seem to radiated from the injection site in 2 lines".  At the time of the report, the reporter indicated that the patient was recovering.  The patient sought unspecified medical attention.  Additional information has been requested.
Patient reports grapefruit sized red bump, sore and warm to the touch, at injection site. Patient contacted office by phone and doctor advised to take Benadryl and ibuprofen and use cool compress at the injection site. Patient reports bump went down slowly but did resolve. Patient currently only has an itch at injection site remaining. Patient states concern and hesitation about getting the second Shingrix vaccination.
Patient came in on 07/25/2022 , received Moderna 2nd Booster. Called the Pharmacy on 07/26/2022 to report reactions she thinks might be related to receiving the vaccine
2 children recv vax 3MAY96 & father who claimed never had chicken pox devel shingles on arm;MD dx shingles;
On 10/15/2021 I got my 1st booster at 1:00PM. On the 12/20/2021 the flu like symptoms stated on the same day few hours later and lasted the whole weekend. I tested positive on 12/27/2021. I went to the ER on Feb. first tele visit 12/27/2021, 2nd tele visit 01/10/2021. I had 2 tele visit. On the first week of march that's when I started feeling better. when I went to the ER they gave me Benadryl, meclizine, while I was in the ER they gave me Tylenol, intravenous Benadryl, intervenes Reglan. it was really bad luckily I was vaccinated otherwise it could have gotten worse. On the 2nd booster I had joint pain, brain fog, fatigue got worst, and lost of concentration. Not sure if its related to the 2nd dose. Still trying to find out. March 14/2022 follow up for ER visit. May 2, 2022 based on the symptoms.
- Sore arm: from time of vaccine to present - Tingles in arm: one hour post-vaccine, lasting 15 minutes - Muscle weakness: three hours post-vaccine, lasting 1 hour - Chills: 7 hours post-vaccine
101.4 temperature; Extreme fatigue; Sore bottoms of feet; Sore skin on my arms and legs; Headache
Pt recv vax on 12/5/98; on 12/6/98 pt exp redness & swelling at vax site; dx=sterile abscess; tx=antibiotics
Fever, body aches, fatigue, nausea, rash, arm pain, diarrhea.
30mins post vax pt noted to be lethargic & warm;next day pt refusing food & drink;found to have blisters in mouth & diaper area;temp ranged from 102 to 104;had febrile sz required medical tx & hospitalization;also exp red bumps all over;sz